nicardipine has been researched along with nky 722 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakeya, N; Kanda, M; Matsui, H; Morishita, S; Osumi, S; Usui, H; Wada, K | 1 |
| Fukata, F; Kanda, M; Kurahashi, K; Matsui, H; Nakamura, S; Shirahase, H; Wada, K | 1 |
| Heshikiri, M; Kimura, R; Ohkura, T; Shirahase, H; Uchida, S; Yamada, S; Yoshimi, A | 1 |
| Fukata, F; Kanda, M; Matsui, H; Morishita, S; Nakamura, S; Shirahase, H; Wada, K | 1 |
| Hashizume, Y; Ishimitsu, T; Kanda, M; Nakamura, S; Shimaji, H; Shirahase, H; Uehara, Y; Wada, K | 1 |
| Fukata, F; Kanda, M; Matsui, H; Nakamura, S; Shirahase, H; Wada, K | 1 |
6 other study(ies) available for nicardipine and nky 722
| Article | Year |
|---|---|
Antihypertensive effect of NKY-722, a new water-soluble 1,4-dihydropyridine derivative, on conscious spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Rats; Rats, Inbred SHR | 1988 |
Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Norepinephrine; Potassium Chloride; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Aorta; Calcium Channel Blockers; Cell Membrane; Cerebral Cortex; Dihydropyridines; Dose-Response Relationship, Drug; Nicardipine; Rats; Rats, Inbred SHR | 1995 |
Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Male; Nicardipine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Wistar; Splanchnic Circulation | 1994 |
Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats.
Topics: Animals; Aorta, Thoracic; Arteries; Blood Pressure; Calcium Channel Blockers; Cerebral Arteries; Dihydropyridines; Epoprostenol; Hypertension; Kidney; Male; Nicardipine; Rats; Renal Artery; Thromboxane A2 | 1994 |
Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent c
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Calcium Channel Blockers; Cerebral Arteries; Dihydropyridines; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nicardipine; Potassium Chloride; Serotonin | 1996 |